BlackRock’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.39M Buy
2,048,526
+78,712
+4% +$185K ﹤0.01% 3792
2025
Q4
$3.76M Buy
1,969,814
+374,175
+23% +$886K ﹤0.01% 3931
2025
Q3
$3.54M Sell
1,595,639
-232,975
-13% -$559K ﹤0.01% 3920
2025
Q2
$2.61M Sell
1,828,614
-3,455,799
-65% -$5.03M ﹤0.01% 3993
2025
Q1
$8.46M Sell
5,284,413
-274,438
-5% -$819K ﹤0.01% 3399
2024
Q4
$20M Buy
5,558,851
+667,916
+14% +$3.32M ﹤0.01% 3056
2024
Q3
$27.9M Buy
4,890,935
+339,425
+7% +$2.04M ﹤0.01% 2820
2024
Q2
$21M Buy
4,551,510
+3,646,504
+403% +$21.7M ﹤0.01% 2962
2024
Q1
$7.39M Sell
905,006
-898,427
-50% -$6.96M ﹤0.01% 3510
2023
Q4
$10.2M Sell
1,803,433
-291,905
-14% -$666K ﹤0.01% 3389
2023
Q3
$3.9M Buy
2,095,338
+8,775
+0.4% +$26.8K ﹤0.01% 3758
2023
Q2
$5.74M Sell
2,086,563
-1,610,179
-44% -$5.18M ﹤0.01% 3668
2023
Q1
$11.6M Buy
3,696,742
+75,609
+2% +$445K ﹤0.01% 3241
2022
Q4
$21.4M Buy
3,621,133
+156,561
+5% +$1.3M ﹤0.01% 3000
2022
Q3
$30.4M Buy
3,464,572
+66,974
+2% +$695K ﹤0.01% 2791
2022
Q2
$25.6M Buy
3,397,598
+257,608
+8% +$2.27M ﹤0.01% 2947
2022
Q1
$76.2M Sell
3,139,990
-265,992
-8% -$6.46M ﹤0.01% 2314
2021
Q4
$110M Buy
3,405,982
+248,775
+8% +$9.84M ﹤0.01% 2163
2021
Q3
$141M Buy
3,157,207
+524,783
+20% +$22.5M ﹤0.01% 1976
2021
Q2
$99.6M Buy
2,632,424
+1,437,932
+120% +$51.5M ﹤0.01% 2254
2021
Q1
$44.2M Buy
1,194,492
+54,901
+5% +$2.18M ﹤0.01% 2695
2020
Q4
$37.8M Buy
+1,139,591
New +$33M ﹤0.01% 2647

Other funds holding CCCC